Incidence of axillary recurrence in 344 sentinel node negative breast cancer patients after intermediate follow-up. A prospective study into the accuracy of sentinel node biopsy in breast cancer patients

Acta Chirurgica Belgica

Volumn 107, Issue 3, 2007, Pages 279-283

  Heuts, E M ^a   Van Der Ent, F W C ^a   Hulsewe K W E ^a   Heeren, P A M ^a   Hoofwijk, A G M ^a  

^a Sittard Geleen Heerlen   (Netherlands)

Author keywords

Axillary recurrence; Breast cancer; Follow up; Sentinel node

Indexed keywords

EID: 34547281052     PISSN: 00015458     EISSN: 25770160     Source Type: Journal    
DOI: 10.1080/00015458.2007.11680056     Document Type: Article

References (38)

1. CONSENSUS CONFERENCE. Adjuvant chemotherapy for breast cancer. JAMA, 1985, 254: 3461-3.
2. CARTER C. L., ALLEN C., HENSON D. E. Relation of tumour size, lymph node status, and survival in 24,740 breast cancer cases. Cancer, 1989, 63: 181-7.
3. KRAG D. N., WEAVER D. L., ALEX J. C., FAIRBANK J. T. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol, 1993, 2: 335-9.
4. GIULIANO A. E., KIRGAN D. M., GUENTHER J. M., MORTON D. L. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Am Surg, 1994, 220: 391-8.
5. ALBERTINI J. J., LYMAN G. H., COX C. et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA, 1996, 276: 1818-22.
6. VERONESI U., PAGANELLI G., GALIMBERTI V. et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet, 1997, 349: 1864-67.
7. TURNER R. R., OLLILA D. W., KRASNE D. L., GIULIANO A. E. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg, 1997, 226: 271-6.
8. KRAG D., WEAVER D., ASHIKAGA T. et al. The sentinel node in breast cancer - a multi-centre validation study. N Engl J Med, 1998, 339: 941-6.
9. VAN DER ENT F. W. C., KENGEN R. A. M., VAN DER POL H. A. G., HOOFWIJK A. G. M. Sentinel node biopsy in 70 unselected patients with breast cancer : increased feasibility by using 10 mCi radio-colloid in combination with a blue dye tracer. Eur J Surg Oncol, 1999, 25: 24-9.
10. FISHER B., REDMOND C., FISHER E. R. et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med, 1985, 312: 674-81.
11. GIULIANO AE., HAIGH PI., BRENNAN MB. et al. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol, 2000, 18: 2553-9.
12. ROUMEN R. M., KUIJT G. P., LIEM I. H., VAN BEEK M. W. Treatment of 100 patients with sentinel node-negative breast cancer without further axillary dissection. Br J Surg, 2001, 88: 1639-43.
13. SCHRENK P., HATZL-GRIESENHOFER M., SHAMIYEH A., WAYNAD W. Follow-up of sentinel node negative breast cancer patients without axillary lymph node dissection. J Surg Oncol, 2001, 77: 165-70.
14. VERONESI U., GALIMBERTI V., ZURRIDA S. et al. Sentinel lymph node biopsy as an indicator for axillary dissection in early breast cancer. Eur J Cancer, 2001, 37: 454-8.
15. CHUNG M. A., STEINHOFF M. M., CADY B. Clinical axillary recurrence in breast cancer patients after a negative sentinel node biopsy. Am J Surg, 2002, 184: 310-4.
16. MEIJER S., TORRENGA H., VAN DER SIJP J. R. (Negative sentinel node in breast cancer patients : a good indicator for continued absence of axillary metastases). Negatieve schildwachtklier bij borstkankerpatienten goede indicator voor het uitblijven van okselmetastasen. Ned Tijdschr Geneeskd, 2002, 146: 942-6.
17. HANSEN N. M., GRUBE B. J., GIULIANO A. E. The time has come to change the algorithm for the surgical management of early breast cancer. Arch Surg, 2002, 137: 1131-5.
18. LOZA J., COLO F., NADAL J., VINIEGRA M., CHACON R. Axillary recurrence after sentinel node biopsy for operable breast cancer. Eur J Surg Oncol, 2002, 28: 897-8.
19. REITSAMER R., PEINTINGER F., PROKOP E., MENZEL C., CIMPOCA W., RETTENBACHER L. Sentinel lymph node biopsy alone without axillary lymph node dissection - follow-up of sentinel lymph node negative breast cancer patients. Eur J Surg Oncol. 2003, 29 : 221-3.
20. PONZONE R., BIGLIA N., MAGGIOROTTO F. et al. Sentinel node dissection as definitive treatment for node negative breast cancer patients. Eur J Surg Oncol, 2003, 29: 703-6.
21. BLANCHARD D.K., DONOHUE J. H., REYNOLDS C., GRANT C. S. Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. Arch Surg, 2003, 138: 482-7.
22. BADGWELL B. D., POVOSKI S. P., ABDESSALAM S. F. et al. Patterns of recurrence after sentinel lymph node biopsy for breast cancer. Ann Surg Oncol, 2003, 10: 376-80.
23. VERONESI U., PAGANELLI G., VIALE G. et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med, 2003, 349: 546-53.
24. JERUSS I. S., WINCHESTER D. J., SENER S. F. et al. Axillary recurrence after sentinel node biopsy. Ann Surg Oncol, 2005, 12: 34-40.
25. SMIDT M. L., JANSSEN C. M., KUSTER D. M., BRUGGINK E. D., STROBBE L. J. Axillary recurrence after a negative sentinel node biopsy for breast cancer : incidence and clinical significance. Ann Surg Oncol, 2005, 12: 29-33.
26. NAIK A. M., FEY J., GEMIGNANI M. et al. The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection : a follow-up study of 4008 procedures. Ann Surg, 2004, 240: 462-8.
27. LANGER I., MARTI W. R., GULLER U. et al. Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases : prospective analysis of 150 patients after SLN biopsy. Ann Surg, 2005, 241: 152-8.
28. KOKKE M. C., JANNINK I., BARNEVELD P. C. et al. Incidence of axillary recurrence in 113 sentinel node negative breast cancer patients : a 3-year follow-up study. Eur J Surg Oncol, 2005, 31: 221-5.
29. VAN WESSEM KJ., MEIJER WS. Sentinel lymph node biopsy in breast cancer : results of intradermal peri-areolar tracer injection and follow-up of sentinel lymph node-negative patients. Breast, 2004, 13: 290-6.
30. TORRENGA H., FABRY H., VAN DER SIJP J. R., VAN DIEST P. J., PIJPERS R., MEIJER S. Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe : a long term follow-up analysis. J Surg Oncol, 2004, 88: 4-7.
31. VERONESI U., GALIMBERTI V., MARIANI L. et al. Sentinel node biopsy in breast cancer : early results in 953 patients with negative sentinel node biopsy and no axillary dissection. Eur J Cancer, 2005, 41: 231-7.
32. ZAVAGNO G., CARCOFORO P., FRANCHINI Z. et al. Axillary recurrence after negative sentinel lymph node biopsy without axillary dissection : a study on 479 breast cancer patients. Eur J Surg Oncol, 2005, 31: 715-20.
33. SANJUAN A., VIDAL-SICART S., ZANON G. et al. Clinical axillary recurrence after sentinel node biopsy in breast cancer : a follow-up study of 220 patients. Eur J Nucl Med Mol Imaging, 2005, 32: 932-6.
34. SWENSON K. K., MAHIPAL A., NISSEN M. J. et al. Axillary disease recurrence after sentinel lymph node dissection for breast carcinoma. Cancer, 2005, 104: 1834-9.
35. DE KANTER A. Y., MENKE-PLUYMERS M. M., WOUTERS M. W., BURGMANS I., VAN GEEL A. N., EGGERMONT A. M. 5-Year follow-up of sentinel node negative breast cancer patients. Eur J Surg Oncol, 2006, 32: 282-6.
36. PIJPERS R., MEIJER S., HOEKSTRA O. S. et al. Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer. J Nucl Med, 1997, 38: 366-8.
37. HEUTS E. M., VAN DER ENT F. W., KENGEN R. A., VAN DER POL H. A., HULSEWE K. W., HOOFWIJK A. G. Results of sentinel node biopsy not affected by previous excisional biopsy. Eur J Surg Oncol, 2006, 32: 278-81.
38. LUINI A., GALIMBERTI V., GATTI G. et al. The sentinel node biopsy after previous breast surgery : preliminary results on 543 patients treated at the European Institute of Oncology. Breast Cancer Res Treat, 2005, 89: 159-63.